TYPHIM Vi, Solution for injection

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. AVAXIM, Suspension for injection in a pre-filled syringe Hepatitis A vaccine (inactivated, adsorbed)

Package leaflet: Information for the user. Poliomyelitis Vaccine (Inactivated) suspension for injection in pre-filled syringe

ACT-HIB powder and solvent for solution for injection Haemophilus influenzae type b Conjugate Vaccine

เอกสารกาก บยาภาษาอ งกฤษ. AVAXIM 160 U Suspension for injection in a prefilled syringe Hepatitis A vaccine (inactivated, adsorbed)

Package leaflet: Information for the user

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

Package leaflet: Information for the user. REVAXIS Suspension for injection in pre-filled syringe

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package Leaflet: Information for the user

Suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

1 What Engerix B is and what it is used for

TYPHIM Vi. Purified polysaccharide capsule of Salmonella typhi (Ty 2 strain) Consumer Medicine Information

Package leaflet: Information for the user REPEVAX. Suspension for injection in pre-filled syringe

Package leaflet: Information for the user

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. STAMARIL, powder and solvent for suspension for injection in pre-filled syringe Yellow fever vaccine (Live)

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the user. HBVAXPRO 5 micrograms, suspension for injection in pre-filled syringe Hepatitis B vaccine (rdna)

Some general information on hepatitis A infection is given at the end of this leaflet.

1. What INACTIVATED INFLUENZA VACCINE (SPLIT VIRION) BP is and what it is used for

Package leaflet: Information for the user. HBVAXPRO 40 micrograms, suspension for injection Hepatitis B vaccine (rdna)

Package Leaflet: Information for the user. Prevenar 13 suspension for injection Pneumococcal polysaccharide conjugate vaccine (13 valent, adsorbed)

1. What INACTIVATED INFLUENZA VACCINE (SPLIT VIRION) BP is and what it is used for

VIVAXIM. Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine. Consumer Medicine Information

Package leaflet: Information for the user. Tuberculin PPD RT23 "SSI" 2 T.U./0.1 ml, solution for injection Tuberculin PPD RT 23

Package leaflet: Information for the user

Package leaflet: Information for the patient

Package leaflet: Information for the user

1. What Faslodex is and what it is used for

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

VIVAXIM Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

Package leaflet: Information for the user. Carmellose sodium

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Package leaflet: Information for the user. ReoPro 2 mg/ml solution for injection or infusion. abciximab

Package leaflet: Information for the patient


IMOVAX POLIO POLIOMYELITIS VACCINE (INACTIVATED) Suspension for injection in prefilled syringe

Package leaflet: Information for the user. HBVAXPRO 10 micrograms, suspension for injection in pre-filled syringe Hepatitis B vaccine (rdna)

Hydrocortisyl Skin Cream 1% Hydrocortisone

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Package leaflet: Information for the user Venofer 20 mg iron /ml Solution for injection or concentrate for solution for infusion Iron Sucrose

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package leaflet: information for the user

Package leaflet: Information for the patient

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

VAQTA Adult, Suspension for injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

Package leaflet: Information for the user. Haemophilus type b and Meningococcal group C conjugate vaccine

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the user. Methylthioninium chloride Proveblue 5 mg/ml solution for injection Methylthioninium chloride

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin

Package leaflet: Information for the user. Tremfya 100 mg solution for injection in pre-filled syringe guselkumab

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

1. What Betahistine dihydrochloride tablets is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

MENACTRA Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate

Package leaflet: Information for the user. Strensiq 100 mg/ml solution for injection (80 mg/0.8 ml) Asfotase alfa

Package leaflet: Information for the user

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

1. What Naropin is and what it is used for

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

Package leaflet: Information for the patient. Zerbaxa 1 g / 0.5 g powder for concentrate for solution for infusion ceftolozane / tazobactam

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the patient

IMOJEV Japanese encephalitis vaccine (live, attenuated)

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Ventolin Injection 500 micrograms/ml salbutamol sulfate

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package leaflet: Information for the user

For further copies of this leaflet, visit emc.medicines.org.uk or call Aspen on +44 (0) Package leaflet: Information for the user

Package leaflet: Information for the user Priorix, powder and solvent for solution for injection in a pre-filled syringe

Package leaflet: Information for the patient. Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

Package Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)

2 What you need to know before you use Zofran Suppositories

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER TYPHIM Vi, Solution for injection Purified Vi Capsular Polysaccharide of Salmonella typhi (Ty 2 Strain). Read all of this leaflet carefully before you are vaccinated because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This vaccine has been prescribed for you only. Do not pass it on to others. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. In this leaflet: 1. What Typhim Vi is and what it is used for 2. Before Typhim Vi is given 3. How Typhim Vi is given 4. Possible side effects 5. How to store Typhim Vi 6. Further information 1. WHAT TYPHIM Vi IS AND WHAT IT IS USED FOR Typhim Vi is a vaccine. Vaccines are used to protect against infectious diseases. This vaccine helps to protect adults and children who are aged 2 years and over against typhoid fever. It may not be effective in children under 2. When the vaccine is given to you or your child, the body s natural defences will produce protection against typhoid fever. Typhoid fever is an infectious disease. Symptoms are a headache with a fever that gets worse over three to four days. Additional symptoms include cough, sore throat and altered behaviour. This vaccine will only protect against typhoid fever. It will not work against any other disease, such as paratyphoid fever or food poisoning. It cannot cause typhoid fever. As with any vaccine, not everyone who receives this vaccine will definitely be protected against typhoid fever. 2. BEFORE TYPHIM Vi IS GIVEN To make sure that this vaccine is suitable for you or your child, it is important to tell your doctor or nurse if any of the points below apply to you or your child. If there is anything you do not understand, ask your doctor or nurse to explain. Do not use this vaccine if you or your child is: allergic (hypersensitive) to Typhim Vi or any of its ingredients (see section 6 for a list of ingredients). allergic (hypersensitive) to formaldehyde, which is used during vaccine production and may be present in small amounts. ill with a high temperature. The vaccination will be delayed until you/your child have recovered. 1

Take special care with this vaccine Tell your doctor or nurse if you or your child has: a blood disorder such as haemophilia (a condition where you bruise or bleed easily) because bleeding may occur at the injection site. a poor or reduced immune system, due to: - corticosteroids, cytotoxic drugs, radiotherapy or any other treatment that weakens the immune system. The doctor or nurse may wait until the course of treatment has finished. - HIV infection or any disease that weakens the immune system. The vaccine may not protect as well as it protects people with normal immune systems. Fainting can occur (mostly in adolescents) following, or even before, any needle injection. Therefore tell your doctor or nurse if you or your child fainted with a previous injection. Receiving other vaccines or medicines This vaccine can generally be given at the same time as other vaccines provided that they are given in different parts of the body (e.g. the other arm or leg) and are not mixed in the same syringe. This vaccine can be given at the same time as other common vaccines including: yellow fever diphtheria tetanus poliomyelitis rabies (prepared on Vero cells) meningitis A + C hepatitis A and hepatitis B Tell your doctor, nurse or pharmacist if you or your child are taking or have recently taken any other medicines, including medicines obtained without a prescription. Pregnancy and breast-feeding If you are pregnant, trying to become pregnant or are breast feeding, tell your doctor or nurse. They will decide whether or not to delay the vaccination. Ask your doctor, nurse or pharmacist for advice before taking any medicine. Driving and using machines Tiredness has been reported in some people after receiving this vaccine so you must take extra care when driving or using machines. If you are affected do not drive or use machines. Important information about some of the ingredients of Typhim Vi Sodium: This vaccine contains less than 1 mmol sodium (23mg) per dose. This is a very small amount so is classed as sodium-free. 3. HOW TYPHIM Vi IS GIVEN The vaccine will be given by a doctor or nurse who has been trained in the use of vaccines and who is equipped to deal with any uncommon severe allergic reaction to the injection. Dosage Typhim Vi is given as a single injection of half a millilitre of the vaccine to adults and children aged 2 years and over. The vaccine should be given at least 2 weeks before protection against typhoid fever is required. Protection lasts for 3 years so you or your child may need another dose after this time. 2

How the vaccine is administered The doctor or nurse will shake the syringe immediately before use and check that the liquid is not discoloured and has no unexpected particles in it. The vaccine is given as an injection into a muscle or deep under the skin, in the outer part of the upper arm or leg. They will avoid giving the injection into a blood vessel. Your doctor or nurse will make a note of the details of the injection. If you have any further questions on the use of this vaccine, ask your doctor, nurse or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines and vaccines, Typhim Vi can cause side effects, although not everybody gets them. Possible Serious Allergic Reactions Severe allergic reaction (anaphylaxis), which may include one or more of the following symptoms: urticaria/skin rashes swelling of the face and/or throat, difficulty in breathing, blue discolouration of the tongue or lips low blood pressure, rapid heart rate and weak pulse, coldness of the skin, dizziness and potentially collapse. When allergic reactions occur, they usually develop very soon after the injection is given, while still in the clinic or doctor s surgery. If any of these symptoms occur after leaving the place where your injection was given, you must consult a doctor IMMEDIATELY. Serum sickness joint pains, skin rashes, enlarged lymph glands and generally feeling unwell. If these symptoms occur, they usually develop 2-4 weeks after receiving the vaccine. If these symptoms occur, consult a doctor as soon as possible. Other Side Effects Very common reactions (reported by more than 1 in 10 people): pain, redness, swelling and hardness in the area where the vaccine was injected Common reactions (reported by less than 1 in 10 but more than 1 in 100 people): fever (a high temperature). Other possible reactions: fainting in response to injection headache asthma diarrhoea, stomach ache, feeling and/or being sick joint/muscle pain rashes that have sometimes been lumpy and itchy tiredness generally feeling unwell Reporting of side effects in the UK If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. Reporting of side effects in Ireland 3

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website: www.hpra.ie; E-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE TYPHIM Vi Keep out of the reach and sight of children. The vaccine must be stored in a refrigerator between 2 C and 8 C. Do not freeze. Keep the syringe in the outer carton in order to protect from light. Do not use Typhim Vi after the expiry date (EXP) which is stated on the carton and syringe label. The expiry date refers to the last day of that month. Vaccines must not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of vaccines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What Typhim Vi contains The active substance is purified Vi capsular polysaccharide of Salmonella typhi (Ty 2 strain). Each 0.5 millilitre dose of Typhim Vi contains 25 micrograms of the active substance. The other ingredients are phenol, sodium chloride, disodium phosphate dihydrate, sodium dihydrogen phosphate dihydrate and Water for injections. What Typhim Vi looks like and contents of the pack Typhim Vi is provided as a solution for injection. The solution is a clear colourless liquid. The vaccine comes in a prefilled glass syringe (without an attached needle) which contains a single 0.5 millilitre injection. The syringes are available as a single unit pack or as a pack of ten. Not all pack sizes may be marketed Marketing Authorisation Holder and Manufacturer The manufacturer responsible for batch release is Sanofi Pasteur at one of the following manufacturing sites: Sanofi Pasteur, Sanofi Pasteur, Campus Mérieux, or Parc Industriel D Incarville, 1541 avenue Marcel Mérieux, 27100 Val de Reuil, 69280 Marcy l Etoile, France France The Marketing Authorisation Holder is: Sanofi Pasteur Europe 14 Espace Henry Vallée 69007 Lyon France Distributed by: United Kingdom: Sanofi One Onslow Street Guildford Surrey GU1 4YS UK 4

Tel: 0845 372 7101 Ireland: sanofi-aventis Ireland T/A SANOFI Citywest Business Campus Dublin 24 Ireland Tel: +353 (0) 1 4035 600 This leaflet was last approved in10/2017. 5